|
1
|
Odden MC, Coxson PG, Moran A, Lightwood
JM, Goldman L and Bibbins-Domingo K: The impact of the aging
population on coronary heart disease in the United States. Am J
Med. 124:827–833.e5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L, Li L, Lewington S, Guo Y,
Sherliker P, Bian Z, Collins R, Peto R, Liu Y, Yang R, et al:
Outdoor temperature, blood pressure, and cardiovascular disease
mortality among 23 000 individuals with diagnosed cardiovascular
diseases from China. Eur Heart J. 36:1178–1185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman
M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C,
et al: Heart disease and stroke statistics-2017 Update: A report
from the American heart association. Circulation. 135:e146–e603.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Basak T, Varshney S, Hamid Z, Ghosh S,
Seth S and Sengupta S: Identification of metabolic markers in
coronary artery disease using an untargeted LC-MS based metabolomic
approach. J Proteomics. 127:169–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wood D, De Backer G, Faergeman O, Graham
I, Mancia G and Pyörälä K: Prevention of coronary heart disease in
clinical practice: Recommendations of the Second Joint Task Force
of European and other Societies on Coronary Prevention. Eur Heart
J. 19:1434–1503. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alkamel A, Shafiee A, Jalali A, Boroumand
M and Nozari Y: The association between premature coronary artery
disease and level of testosterone in young adult males. Arch Iran
Med. 17:545–550. 2014.PubMed/NCBI
|
|
7
|
Scheuner MT, Whitworth WC, McGruder H,
Yoon PW and Khoury MJ: Familial risk assessment for early-onset
coronary heart disease. Genet Med. 8:525–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Speidl WS, Nikfardjam M, Niessner A,
Jordanova N, Zorn G, Maurer G, Schreiber W, Wojta J and Huber K:
Premature compared with late onset of coronary artery disease:
Young patients show a severe defect in fibrinolytic response to
venous occlusion. Blood Coagul Fibrinolysis. 18:165–171. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reibis R, Treszl A, Wegscheider K,
Bestehorn K, Karmann B and Völler H: Disparity in risk factor
pattern in premature versus late-onset coronary artery disease: A
survey of 15,381 patients. Vasc Health Risk Manag. 8:473–481. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chinese Society of Cardiology of Chinese
Medical Association; Editorial Board of Chinese Journal of
Cardiology, . Guideline and consensus for the management of
patients with non-ST-elevation acute coronary syndrome (2016).
Zhonghua Xin Xue Guan Bing Za Zhi. 45:359–376. 2017.PubMed/NCBI
|
|
11
|
Badimon L, Bugiardini R and Cubedo J:
Pathophysiology of acute coronary syndromes in the elderly. Int J
Cardiol. 222:1105–1109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Editorial Board of Chinese Journal of
Cardiologyvascular Diseases, . Guidelines for the diagnosis and
treatment of non-ST-segment elevation acute coronary syndrome,
2016. Chin Soc Cardiol. 45:359–376. 2017.(In Chinese).
|
|
13
|
Amsterdam EA, Wenger NK, Brindis RG, Casey
DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF,
Kontos MC, et al: 2014 AHA/ACC guideline for the management of
patients with non-ST-elevation acute coronary syndromes: A report
of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines. J Am Coll Cardiol. 64:e139–e228.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ibanez B, James S, Agewall S, Antunes MJ,
Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA,
Halvorsen S, et al: 2017 ESC Guidelines for the management of acute
myocardial infarction in patients presenting with ST-segment
elevation: The Task Force for the management of acute myocardial
infarction in patients presenting with ST-segment elevation of the
European Society of Cardiology (ESC). Eur Heart J. 39:119–177.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grundy SM, Cleeman JI, Merz CN, Brewer HB
Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ;
National Heart, Lung, Blood Institute, ; et al: Implications of
recent clinical trials for the National Cholesterol Education
Program Adult Treatment Panel III guidelines. Circulation.
110:227–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pelletier R, Khan NA, Cox J, Daskalopoulou
SS, Eisenberg MJ, Bacon SL, Lavoie KL, Daskupta K, Rabi D,
Humphries KH, et al: Sex versus gender-related characteristics:
Which predicts outcome after acute coronary syndrome in the young?
J Am Coll Cardiol. 67:127–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pelletier R, Choi J, Winters N, Eisenberg
MJ, Bacon SL, Cox J, Daskalopoulou SS, Lavoie KL, Karp I, Shimony
A, et al: Sex differences in clinical outcomes after premature
acute coronary syndrome. Can J Cardiol. 32:1447–1453. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
2010 Chinese guidelines for the prevention
and treatment of hypertension, . Chin J front Med Sci (Electronic
Version). 3:42–90. 2011.(In Chinese).
|
|
19
|
Xu, Guobin Zhu, Lihua Xia and Tie'an:
Determination of creatinine dehydrogenase by creatinine and amidine
hydrolase by creatinine enzymatic method. J Clin Laboratory Med.
19:1492001.
|
|
20
|
Gochman N and Schmitz JM: Automated
determination of uric acid, with use of a uricase-peroxidase
system. Clin Chem. 17:1154–1159. 1971.PubMed/NCBI
|
|
21
|
Harry L and Page Jr MD: The Judkins
technique. Catheter cardiovasc interv. 5:187–189. 1979. View Article : Google Scholar
|
|
22
|
Smith SC Jr, Dove JT, Jacobs AK, Kennedy
JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams
DO, et al: ACC/AHA guidelines for percutaneous coronary
intervention (revision of the 1993 PTCA guidelines)-executive
summary: A report of the American College of Cardiology/American
Heart Association task force on practice guidelines (Committee to
revise the 1993 guidelines for percutaneous transluminal coronary
angioplasty) endorsed by the Society for Cardiac Angiography and
Interventions. Circulation. 103:3019–3041. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gensini GG: A more meaningful scoring
system for determining the severity of coronary heart disease. Am J
Cardiol. 51:6061983. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei W, Zhijun W and Xinying C: Early onset
and late onset coronary heart disease risk factors of coronary
artery disease. World Latest Med Inform (Electronic Version).
16(8): 18–20. 2016.PubMed/NCBI
|
|
25
|
Lloyd-Jones DM, Larson MG, Beiser A and
Levy D: Lifetime risk of developing coronary heart disease. Lancet.
353:89–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dosi R, Bhatt N, Shah P and Patell R:
Cardiovascular disease and menopause. J Clin Diagn Res. 8:62–64.
2014.
|
|
27
|
Hochner-Celnikier D, Manor O, Gotzman O,
Lotan H and Chajek-Shaul T: Gender gap in coronary artery disease:
Comparison of the extent, severity and risk factors in men and
women aged 45–65 years. Cardiology. 97:18–23. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Committee of Women Physician in Chinese
College Cardiovascular Physicians; Women's Health Work Group in
Chinese Society of Cardiology, . Expert consensus for the
prevention of cardiovascular disease in Chinese women. Zhonghua Nei
Ke Za Zhi. 56:472–476. 2017.(In Chinese). PubMed/NCBI
|
|
29
|
Park JY, Lee SH, Shin MJ and Hwang GS:
Alteration in metabolic signature and lipid metabolism in patients
with angina pectoris and myocardial infarction. PLoS One.
10:e01352282015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chapman MJ, Ginsberg HN, Amarenco P,
Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen
PT, Kuivenhoven JA, et al: Triglyceride-rich lipoproteins and
high-density lipoprotein cholesterol in patients at high risk of
cardiovascular disease: Evidence and guidance for management. Eur
Heart J. 32:1345–1361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kugiyama K, Sakamoto T, Misumi I, Sugiyama
S, Ohgushi M, Ogawa H, Horiguchi M and Yasue H: Transferable lipids
in oxidized low-density lipoprotein stimulate plasminogen activator
inhibitor-1 and inhibit tissue-type plasminogen activator release
from endothelial cells. Circ Res. 73:335–343. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van de Woestijne AP, Wassink AM, Monajemi
H, Liem AH, Nathoe HM, van der Graaf Y and Visseren FL; SMART study
group, : Plasma triglyceride levels increase the risk for recurrent
vascular events independent of LDL-cholesterol or
nonHDL-cholesterol. Int J Cardiol. 167:403–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jellinger PS, Handelsman Y, Rosenblit PD,
Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK,
Bell DSH and Mechanick JI: American Association Of Clinical
Endocrinologists And American College Of Endocrinology Guidelines
For Management Of Dyslipidemia And Prevention Of Cardiovascular
Disease. Endocr Pract. 23 (Suppl 2):1–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jellinger PS, Handelsman Y, Rosenblit PD,
Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK,
Bell DSH, Mechanick JI, et al: American association of clinical
endocrinologists and American college of endocrinology guidelines
for management of dyslipidemia and prevention of cardiovascular
disease. Endocr Pract. 23 (Suppl 2):S1–S87. 2017. View Article : Google Scholar
|
|
35
|
Sianos G, Morel MA, Kappetein AP, Morice
MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME,
Mohr FW and Serruys PW: The SYNTAX score: An angiographic tool
grading the complexity of coronary artery disease.
EuroIntervention. 1:219–227. 2005.PubMed/NCBI
|
|
36
|
Mairesse GH, Moran P, Van Gelder IC,
Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J,
Varma N, et al: Screening for atrial fibrillation: A European Heart
Rhythm Association (EHRA) consensus document endorsed by the Heart
Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS),
and Sociedad Latinoamericana de Estimulación Cardíaca y
Electrofisiología (SOLAECE). Europace. 19:1589–1623. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li R: Guide to Prevention and Treatment of
Essential Hypertension in China 2010: Introduction 2010 Essentials.
Chin J General Pract. 11:8–10. 2012.(In Chinese).
|
|
38
|
Shahim B, De Bacquer D, De Backer G,
Gyberg V, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D,
Rydén L, et al: The prognostic value of fasting plasma glucose,
two-hour postload glucose, and HbA1c in patients with
coronary artery disease: A report from EUROASPIRE IV: A survey from
the european society of cardiology. Diabetes Care. 40:1233–1240.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Emerging Risk Factors Collaboration,
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio
E, Ingelsson E, Lawlor DA, Selvin E, et al: Diabetes mellitus,
fasting blood glucose concentration, and risk of vascular disease:
A collaborative meta-analysis of 102 prospective studies. Lancet.
375:2215–2222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang X, Dong L, Wang Q and Xie X: The
relationship between fasting plasma glucose and MPO in patients
with acute coronary syndrome. BMC Cardiovasc Disord. 15:932015.
View Article : Google Scholar : PubMed/NCBI
|
